RT Journal Article
SR Electronic
T1 Kinetics of Immunoglobulins in Septic Shock Patients Treated with an IgM and IgA-Enriched Intravenous Preparation: an Observational Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.08.20189183
DO 10.1101/2020.09.08.20189183
A1 Berlot, Giorgio
A1 Scamperle, Alice
A1 Istrati, Tatiana
A1 Dattola, Roberto
A1 Longo, Irene
A1 Chillemi, Antonino
A1 Baronio, Silvia
A1 Quarantotto, Giada
A1 Roman-Pognuz, Erik
A1 Tomasini, Ariella
A1 Bixio, Mattia
YR 2020
UL http://medrxiv.org/content/early/2020/09/09/2020.09.08.20189183.abstract
AB Objective to assess the variations of the blood levels of immunoglobulins (Ig) in septic shock patients treated with an Ig preparation enriched in IgM and IgA (eIg).Design The blood levels of Ig in survivors (S) and non-survivors (NS) of a group of septic shock patients were measured before the initial administration (D0) and one (D1), four (D4) and seven (D7) days thereafter. The SAPS II score, the capillary permeability, the primary site of infection, the antibiotic appropriateness, the microorganisms isolated and the outcome at 28 days were also assessed.Results In the interval D0-D7 the IgM increased significantly only in the S while remained stable in NS; the IgA significantly increased in both groups; the IgG did not vary significantly in both groups. At D7 the capillary permeability significantly decreased in S but not in NS.Conclusions The kinetics of the different classes of Ig after eIg were different between S and NS. This could be related either to (a) different capillary permeability in the two groups and/or (b) higher Ig consumption in NS. Further studies to confirm the benefits of eIg in the treatment of sepsis syndrome, to define the specific target population and the correct eIg dose are warranted.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The local Ethical Committe was informed of the study and authorized the data gathering because (a) the eIg preparation is routinely used as part of the standard of care of patients with septic shock; (b) the patients were not randomized; and (c) at the time of hospital or ICU admission the patients or their next of kin, subscribed a form allowing the use of their personal date (i.e. blood chemistries, cultures etc) for research purposes provided that they remain anonymous. 2.2.2016, 36.reg deg, Ethical Committee of the Azienda Sanitaria Universitaria di TriesteAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall relevant data are available for the rewievers